Takarazuka, Japan

Fujiki Yamato

This inventor holds 3 USPTO granted patents. Top assignee: Novartis Ag. Active years: 2001-2005.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Fujiki Yamato. Retrieved from https://idiyas.com/inventor/fujiki-yamato

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 33.3

Average Co-Inventor Count = 5.0

ph-index = 3

Forward Citations = 18(Granted Patents)


Company Filing History:


Years Active: 2001-2005

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Fujiki Yamato: Innovator in Pharmaceutical Patents

Introduction

Fujiki Yamato is a notable inventor based in Takarazuka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of solid oral dosage forms. With a total of 3 patents to his name, Yamato's work has had a meaningful impact on medication delivery systems.

Latest Patents

One of his latest patents focuses on solid oral dosage forms of valsartan. This invention addresses the need for effective and reliable medication formulations, enhancing the therapeutic efficacy of valsartan for patients.

Career Highlights

Yamato is currently associated with Novartis AG, a leading global healthcare company. His role at Novartis has allowed him to further his research and development efforts in the pharmaceutical industry.

Collaborations

Throughout his career, Yamato has collaborated with esteemed colleagues, including Robert Frank Wagner and Yoshimitsu Katakuse. These partnerships have fostered innovation and contributed to the advancement of pharmaceutical technologies.

Conclusion

Fujiki Yamato's contributions to the field of pharmaceuticals, particularly through his patents and collaborations, highlight his role as a key innovator in medication delivery systems. His work continues to influence the industry and improve patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…